Kangmei Pharma | 600518 - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
Akebia Therapeutics USD -11.24M 12.39M 2025-12
Alaunos Therapeutics USD -7.84M 633K 2023-12
Avita Medical AUD -11.64M 12.13M 2025-12
Cspc Pharmaceutical CNY 505.59M 706M 2025-12
Dianthus Therapeutics USD -40.83M 23.6M 2026-03
Genomma Lab Internacional MXN 534.73M 109.37M 2026-06
Hypermarcas BRL 276.14M 163.07M 2026-03
Ionis Pharmaceuticals USD -114M 21M 2026-06
IQVIA Holdings USD 301M 5.92B 2026-06
Jiangsu Hengrui CNY 2.4B 161.31M 2026-06
Kangmei Pharma CNY -14.01M 16.08M 2026-03
Moderna USD -1.33B 535M 2026-03
Organon & Co USD 183M 30M 2026-06
Revvity USD 187.24M 137.25M 2026-06
Sh Fosun Pharma CNY 1.36B 82.9M 2026-03
Tectonic Therapeutic USD -18.97M 63K 2025-12
Viatris USD -247.3M 95.7M 2026-03
Wuxi Apptec CNY 7.91B 2.3B 2026-06
Xeris Pharmaceuticals USD 2.23M 8.85M 2026-03
Zz Pientze Pharmaceu CNY 876.07M 352.96M 2026-03